Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
When is a “Journal” … not a Journal?
By Dr. David Edward Marcinko; MBA, CMP™
Publisher-in-Chief
Allow me to begin this post by making the unusual disclosure that I was the Editor-in-Chief of a print guide in healthcare finance and economics [aka periodical or journal].
Formally, the title was: Healthcare Organizations [Financial Management Strategies]. At 2 volumes, and more than 1,200 pages, it was quite a job to update it quarterly. And, with more than two dozen contributing authors, it was a labor of love indeed. Alas … no more!
Varying Levels of Credibility
Now, we doctors know that medical journals are not all alike. There are different levels of “credibility.” Some are peer-reviewed, others not. Some are trade magazines. Frankly, some “real” journals are better, and more respected than others. Some entrenched journals are in decline, while other emerging journals are leading-edge in the health 2.0 space. Still others, like the formerly esteemed Journal of the American Medical Association [JAMA], have been accused of outright censorship.
Link: https://healthcarefinancials.wordpress.com/2009/04/02/is-jama-censoring-physician-dissent/
Adventures
Of course, doctors also know that pharmaceutical companies routinely offer us reprints of articles from medical journals that are favorable to their products. But, news of a Merck-sponsored publication for doctors in Australia has come to light in a personal injury lawsuit over Vioxx. It raised more than a few eyebrows in international medical publishing circles. It may have even crossed the line of journalistic, not to mention medical, ethics.
Read: Merck Paid for Medical ‘Journal’ Without Disclosure; by Natasha Singer, May 13, 2009.
Mis-Adverntures
Tracy Staton wrote more about these mis-adventures in a story, dated May 14, 2009, in FiercePharma.
Analysis and Apology
Analysis in the Pipeline: http://seekingalpha.com/article/136942-merck-and-elsevier-cross-the-line-in-joint-medical-journal?source=yahoo
Libology Mea Culpa: http://www.libology.com/blog/tag/excerpta-medica
Assessment
Perhaps; Merck ought to read our Medical-Executive Post on health journalists?
Link: https://healthcarefinancials.wordpress.com/2009/03/17/battered-health-journalists
Or, our Medical-Executive Post on medical experts, reporters and journalists?
Link: https://healthcarefinancials.wordpress.com/2009/03/09/healthcare-experts-versus-health-journalists
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Link: http://feeds.feedburner.com/HealthcareFinancialsthePostForcxos
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
Share this:
Filed under: "Doctors Only", Breaking News, Career Development, Drugs and Pharma, Ethics, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., Op-Editorials, Recommended Books, Risk Management | Tagged: big-pharma, david marcinko, Drugs, JAMA, medical journals, Merck, Natasha Singer, pharmaceticals, Tracy Staton, Vioxx, www.healthcarefinancials.com | 12 Comments »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 